Forecast Johnson & Johnson Shares Hit Record High as Uptrend Holds Above 243.75

Long-term support for prices continues to come from monetary factors, although recent negative court rulings have slowed the upward momentum. Last week’s labor market data showed a decline in unemployment from 4.4% to 4.3% and an increase in nonfarm payrolls by 130.0 thousand versus expectations of 66.0 thousand. Together with a slowdown in the consumer price index from 2.7% to 2.4% year-on-year and in core inflation from 2.6% to 2.5%, this points to the resilience of the U.S. economy. This is especially important for a company focused on domestic consumers and creates conditions for further easing of U.S. Federal Reserve monetary policy. At the same time, Fed officials remain cautious, noting that inflation is still above the 2.0% target.

On the other hand, on Friday a Pennsylvania jury awarded $250.0 thousand ($50.0 thousand in compensatory damages and $200.0 thousand in punitive damages) to the family of Gail Emerson, who accused the corporation of producing talc-based baby powder that allegedly caused cancer, claiming that management was aware of the risks but took no action. The so-called “talc case” has generated significant public attention and increased the company’s legal expenses, making investors more cautious toward the stock. Currently, around 67.0 thousand lawsuits are pending in U.S. courts accusing Johnson & Johnson of manufacturing and distributing products harmful to health, with legal costs already totaling $4.69 billion. Nevertheless, analysts assess the company’s long-term outlook positively: its financial position allows it to withstand such legal challenges, while its oncology and orthopedic drug portfolios continue to expand, leading management to expect revenue of $100.5 billion in 2026.

Support and resistance levels

The instrument has exited the ascending channel through its upper boundary and is testing the 243.75 level (Murray [7/8]). A sustained move above this level would allow prices to reach the 250.00 area (Murray [8/8]) and 262.50 (Murray [+2/8]). However, a break below the middle Bollinger Band at 231.25 (Murray [5/8]) could trigger a decline toward 218.75 (Murray [3/8]) and 212.50 (Murray [2/8]).

Technical indicators maintain a buy signal: Bollinger Bands are turning upward, the MACD histogram is expanding in positive territory, and the Stochastic is exiting the overbought zone, which does not rule out a limited correction.

Resistance levels: 243.75, 250.00, 262.50.

Support levels: 231.25, 218.75, 212.50.

Trading scenarios and Johnson & Johnson price forecast

Long positions can be opened above 243.75 with targets at 250.00 and 262.50 and a stop-loss at 239.40. Time horizon: 5–7 days.

Short positions can be opened below 231.25 with targets at 218.75 and 212.50 and a stop-loss at 240.50.